FDA's Blueprint to Battle Invisible Heartburn Hell
Published Date: 9/17/2025
Notice
Summary
The FDA just dropped a draft guide to help drug makers create better treatments for adults with symptomatic nonerosive gastroesophageal reflux disease (sGERD), a type of acid reflux without visible damage. This guide explains how to design clinical trials that prove new drugs work and are safe. Drug developers should check it out soon to speed up their research and bring relief to patients faster.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in